Windtree Therapeutics, Inc. (WINT) Appoints Leanne Kelly to its Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Windtree Therapeutics, Inc. (WINT) Appoints Leanne Kelly to its Board

Windtree Announces the Addition of Leanne Kelly to Its Board of Directors

January 13, 2025 8:00 AM EST

WARRINGTON, Pa., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (Windtree or the Company) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases, today announced the appointment of Leanne Kelly to its board of directors (Board). Ms. Kelly has significant public company executive experience and joins the Board as an independent director and chair of the audit committee.

Ms. Kelly has served as GRI Bios Chief Financial Officer since April 2023. She brings over 20 years of experience leading private and publicly traded companies across life science,... More